Abstract
Wide variation in responses to neuromuscular blocking agents is well described but typically underappreciated in clinical practice. We present 2 patients with unexpected responses to rocuronium, despite being otherwise unremarkable. Quantitative neuromuscular monitoring provided clear documentation of the events, providing illustrations of these atypical responses.
Original language | English (US) |
---|---|
Pages (from-to) | 190-192 |
Number of pages | 3 |
Journal | A & A case reports |
Volume | 9 |
Issue number | 7 |
DOIs | |
State | Published - Oct 1 2017 |